Literature DB >> 19122680

Mammalian acatalasemia: the perspectives of bioinformatics and genetic toxicology.

Masana Ogata1, Da-Hong Wang, Keiki Ogino.   

Abstract

The molecular defects in the catalase gene, levels of m-RNA and properties of the residual catalase studied by scientists are reviewed in human (Japanese, Swiss and Hungarian) and non-human (mouse and beagle dog) acatalasemia with reference to the bioinformatics. Japanese acatalasemia-I, the G to A transition at the fifth position of intron 4 of the catalase gene, limited the correct splicing of the mRNA and synthesized trace catalase with normal properties. Hungarian acatalasemia type C showed a splicing mutation. In the Japanese acatalasemia II and the type A and B of Hungarian acatalasemia, the deletion or insertion of nucleotides was observed in the coding regions, and the frame shift altered downstream amino acid sequences and formed truncated proteins. In the Hungarian acatalasemia D, the substitution of a nucleotide in the exon was found. In mouse and beagle dog acatalasemia, the substitution of nucleotides in the coding regions was also observed. Studies of residual catalase in Swiss, mouse and beagle dog acatalasemia showed that aberrant catalase protein degrades more quickly than normal catalase in cells. The experimental research in genetic toxicology concerning the effect of oxidative stressors (nitrogen monoxide, nitrogen dioxide and so on) on Japanese acatalasemic blood and acatalasemic mice is described. The clinical features of Japanese and Hungarian acatalasemic subjects are also described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19122680     DOI: 10.18926/AMO/30951

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  8 in total

Review 1.  Mercury-induced motor and sensory neurotoxicity: systematic review of workers currently exposed to mercury vapor.

Authors:  Cheryl A Fields; Jonathan Borak; Elan D Louis
Journal:  Crit Rev Toxicol       Date:  2017-07-18       Impact factor: 5.635

2.  Acatalasia was omitted.

Authors:  Antonias G Tsamaloukas
Journal:  Dtsch Arztebl Int       Date:  2015-03-27       Impact factor: 5.594

Review 3.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  Status of Catalase, Glutathione Peroxidase, Glutathione S-Transferase, and Myeloperoxidase Gene Polymorphisms in Beta-Thalassemia Major Patients to Assess Oxidative Injury and Its Association with Enzyme Activities.

Authors:  Poonam Tripathi; Sarita Agarwal; Satyendra Tewari; Kausik Mandal
Journal:  J Pediatr Genet       Date:  2021-04-12

Review 5.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

6.  The role of catalase in pulmonary fibrosis.

Authors:  Nao Odajima; Tomoko Betsuyaku; Katsura Nagai; Chinatsu Moriyama; Da-Hong Wang; Tomoko Takigawa; Keiki Ogino; Masaharu Nishimura
Journal:  Respir Res       Date:  2010-12-29

7.  Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis.

Authors:  Keiichi Takiue; Hitoshi Sugiyama; Tatsuyuki Inoue; Hiroshi Morinaga; Yoko Kikumoto; Masashi Kitagawa; Shinji Kitamura; Yohei Maeshima; Da-Hong Wang; Noriyoshi Masuoka; Keiki Ogino; Hirofumi Makino
Journal:  BMC Nephrol       Date:  2012-03-25       Impact factor: 2.388

8.  Catalase S-Glutathionylation by NOX2 and Mitochondrial-Derived ROS Adversely Affects Mice and Human Neutrophil Survival.

Authors:  Sheela Nagarkoti; Megha Dubey; Samreen Sadaf; Deepika Awasthi; Tulika Chandra; Kumaravelu Jagavelu; Sachin Kumar; Madhu Dikshit
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.